Larvol Delta - Inhibikase-Therapeutics-Highlights-Unblinded-Functional-Analysis-from-the-201-Trial-of-Risvodetinib-in-Untreated-Parkinsons-Disease-and-Provides-Update-on-Ongoing-Enrollment

risvodetinib (IkT-148009) - Inhibikase, Clintrex

https://www.globenewswire.com/news-release/2023/10/16/2760510/0/en/Inhibikase-Therapeutics-Highlights-Unblinded-Functional-Analysis-from-the-201-Trial-of-Risvodetinib-in-Untreated-Parkinson-s-Disease-and-Provides-Update-on-Ongoing-Enrollment.html

Oct 16, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next